Clinical studies show RL infusion during pancreatitis allows early improvement in systemic inflammatory response syndrome (SIRS) and C-reactive protein (CRP) when compared with saline infusion [7,8,9], but not survival [10]. This evidence concerns the gene CRP and systemic inflammatory response syndrome.